From the Lab to the Ballot: Pharmacist Chris Orazulike’s Bold Disease Theory, His Primary Battle With Peter Obi and Now He Dedicates Same Theory to His Erstwhile Rival
By Samuel Nworah, Abuja
Can a single organ hold the key to fighting all disease? And what happens when the man who says so loses a party ticket to a national figure — but keeps fighting?
For Pharmacist Chris Orazulike, the two questions are now intertwined.
The Nigerian researcher and politician has spent years developing a theory that the liver may be central to preventing, treating — even curing — every disease. He also recently contested the National Democratic Congress (NDC) presidential primary, seeking the party’s 2027 ticket. He lost — to Peter Obi, the former Anambra governor and NDC presidential candidate for 2027.
Paradoxically, he now plans to dedicate his Redox Theory of Diseases to his erstwhile political rival, Peter Obi, come December 8 this year.
Orazulike, who hails from Anambra State — the same state as Obi — had declared his intention to contest the presidency under the NDC after defecting from the All Progressives Grand Alliance (APGA). At a press conference in Abuja, he said his primary motivation was to ensure that “votes count,” stressing that credible elections remain the foundation for Nigeria’s progress.
“A free and fair election is all that Nigeria needs to move forward,” he said.
He lost the primary. His research — and his “Our Votes Must Count” movement — continue.
The science: a theory for all disease
At the heart of Orazulike’s public life is a bold scientific proposition. His paper, “Global disease burden: new prospects of a panacea through liver-dependent immunomodulation,” proposes what he calls the Liver-Redox Disease Theory (LRDT) also known simply as the Redox Theory of Diseases (RTD).
Stated plainly: “All diseases are due to disorderly cell death resulting from pro-oxidant induced aberrant redox reactions, which leads to immune compromise in the absence of optimal liver function.”
In layman’s terms, Orazulike argues that when the liver is not functioning optimally, the body’s chemical balance — its redox state, the equilibrium between harmful “pro-oxidant” molecules and protective antioxidants — goes awry. This triggers disordered cell death and weakens the immune system, opening the door to disease.
He reviewed 173 publications across Medline, ScienceDirect and ResearchGate to build the case. The liver, he notes, is packed with 1,000 to 2,000 mitochondria per cell and produces glutathione, the body’s most abundant antioxidant. It also stores vitamins A, B12, D and E, produces immune-signalling proteins, and metabolises drugs and toxins.
From this, he concludes that disease cannot occur under optimal liver-redox balance — and that optimizing that balance through hepatoprotection, nutrition and reduced toxin exposure could prevent, treat and potentially cure disease. He calls the approach hepatoimmunotherapy (HIT).
Critically, this is a theoretical framework, not a proven cure. The paper is a literature review with no clinical trials or patient data. Orazulike himself says HIT “can be tested” — and at the press conference, he revealed that his food-based nutrient product, the “FUDELT method,” is undergoing preparations for regulatory evaluation and clinical trials.
The policy: healthcare affordability, agriculture and electoral integrity
Orazulike’s political platform reflects his scientific background. He identified affordability as a major challenge in Nigeria’s healthcare system and called for reforms to improve access to services — a natural extension of his research interest in preventive, nutrition-based health.
He also emphasised the need for expanded irrigation infrastructure to boost agricultural productivity, particularly in northern Nigeria — linking food security to national health.
And he unveiled a non-partisan initiative, the “Our Votes Must Count” movement, aimed at countering electoral malpractice through legal and strategic means. “We are not going to fold our hands and watch people rig elections,” he said. “We will use lawful and intellectual strategies to ensure the will of the people prevails.”
The Peter Obi primary: same party, same state, different vision
Orazulike’s bid placed him in direct competition with Peter Obi, now the NDC’s presidential candidate for 2027. The parallels are striking: both men hail from Anambra State; both have built their political identity around electoral integrity — Obi’s “take back Nigeria” movement and Orazulike’s “Our Votes Must Count” share the same DNA; and both frame their agendas around cost-efficiency and human capital.
But they were rivals for the same ticket, and their emphases differed. Obi’s signature policy is a production-led economy — shifting Nigeria from importing to making.
Orazulike’s is health affordability and disease prevention, grounded in his liver-redox research. If Obi’s thesis is that Nigeria must produce more, Orazulike’s is that Nigerians must live healthier to produce at all — a complementary vision, but a competing candidacy.
Obi won the primary. Orazulike acknowledged the challenge of contesting against established political structures and a national figure like Obi, but expressed confidence that a transparent process would level the playing field.
“In a truly free and fair election, Nigerians will decide their future,” he said.
About the author
Pharmacist Chris Orazulike is a Nigerian researcher and politician from Anambra State. He contested the NDC presidential primary for the 2027 election. His paper, “Global disease burden: new prospects of a panacea through liver-dependent immunomodulation,” has been published by the International Journal of Global Biosciences and referenced by some researchers . He is the founder of the “Our Votes Must Count” movement and is developing the FUDELT method for regulatory evaluation and clinical trials.
The bottom line
Orazulike’s theory is bold — perhaps too bold for some. The claim that a single organ holds the key to all disease will invite scrutiny, and rightly so. But that is how science advances: with testable hypotheses that challenge convention. Whether HIT becomes a breakthrough or a footnote — and whether his political career rebounds from a primary loss to a national figure — Orazulike has asked a question worth asking: can we find a common pathway through which all disease must pass?
For a country battling a heavy disease burden and a history of disputed elections, both questions are worth taking seriously.
